Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.
Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk ...
5don MSN
The White House Just Announced Reduced Costs For Weight Loss Drugs—Here's What That Means For You
One of the biggest gripes around weight loss medications like Wegovy and Zepbound is the high price tag. At $1,000 or more a ...
In 2026 patents on semaglutide (the active ingredient in Wegovy and Ozempic) will expire in large emerging markets including ...
Early results of Eli Lilly’s next generation of weight loss drugs appear to show promise, possibly leading to even faster ...
The race to develop the next generation of weight loss drugs has taken an interesting new turn. In recent research, Eli Lilly ...
Eli Lilly Strikes a Landmark Pricing Deal With the U.S. for Its Billion-Dollar Weight Loss Drugs. Here's What This Means for ...
Competition is working, even as the FTC meddles in a takeover fight in a way that helped Pfizer.
Eli Lilly and Novo Nordisk are cutting prices for popular weight-loss drugs in deals struck with the Trump administration, ...
Eli Lilly's weight-loss therapy Mounjaro became India's top-selling drug by value in October, data showed on Friday, ...
The White House is nearing an agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to offer some of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback